A) Cultured SK-BR-3, HCC1419, JIMT-1, and MDA-MB-453 cells were treated either with Th1 cytokines (TNF-α plus IFN-γ; 20 and 12.5ng/ml respectively), Lapatinib (0–4μM), or Lapatinib plus Th1 cytokines. After 72 hours incubation, resazurin sodium salt was added to each well and further incubated until color change was noted, and optical densities of supernatants read spectrophotometrically at 630nM. B) Statistical analysis at 2μm concentration of lapatinib. Shown are composite data from at least three trials per cell line expressed as mean optical density +/- SEM. Statistical significance was determined by one-way ANOVA followed by the Holm-Sidak multiple comparison test.</p
Additional file 1: Fig. S1. (A) CRISPR-Cas9 library sequencing data analysis workflow. (B) The distr...
<p>A. Cellular proliferation of Calu3 and SkBr3 cells treated with different concentrations of lapat...
<p><b>A,</b> Lapatinib sensitivity curves in the parental OE19 and two lapatinib-resistant (LR) subc...
Cultured SK-BR-3, BT-474 and MDA-MB-468 cells were treated either with Th1 cytokines (TNF-α plus IFN...
Cultured SK-BR-3, JIMT-1, HCC1419, and MDA-MB-453 cells were treated with increasing concentrations ...
Cultured SK-BR-3, BT-474 and MDA-MB-468 cells were treated either with Th1 cytokines (TNF-α plus IFN...
Cultured HCC1419, JIMT-1 and MDA-MB-453 cells were treated either with Th1 cytokines (TNF-α plus IFN...
A) Cultured SK-BR-3, BT-474 and MDA-MB-468 cells were treated either with Th1 cytokines (TNF-α plus ...
The HER family of receptor tyrosine kinases has been linked to deregulation of growth and proliferat...
The HER family of receptor tyrosine kinases has been linked to deregulation of growth and proliferat...
SK-BR-3 and MDA-MB-468 cells were treated with either Th1 cytokines (TNF-α plus IFN-γ; 20 and 12.5ng...
A) IFN-γ ELISPOT assayof unfractionated human PBMCs from four unique donors stimulated with MHC clas...
Lapatinib is a specific HER1 and 2 targeted tyrosine kinase inhibitor now widely used in combination...
A) SKBR3 breast cancer cells were cultured in lapatinib till they gained resistance and started acti...
<p>A, Schematic showing the procedure to obtain cells resistant to anti-HER2 therapies <i>in vitro</...
Additional file 1: Fig. S1. (A) CRISPR-Cas9 library sequencing data analysis workflow. (B) The distr...
<p>A. Cellular proliferation of Calu3 and SkBr3 cells treated with different concentrations of lapat...
<p><b>A,</b> Lapatinib sensitivity curves in the parental OE19 and two lapatinib-resistant (LR) subc...
Cultured SK-BR-3, BT-474 and MDA-MB-468 cells were treated either with Th1 cytokines (TNF-α plus IFN...
Cultured SK-BR-3, JIMT-1, HCC1419, and MDA-MB-453 cells were treated with increasing concentrations ...
Cultured SK-BR-3, BT-474 and MDA-MB-468 cells were treated either with Th1 cytokines (TNF-α plus IFN...
Cultured HCC1419, JIMT-1 and MDA-MB-453 cells were treated either with Th1 cytokines (TNF-α plus IFN...
A) Cultured SK-BR-3, BT-474 and MDA-MB-468 cells were treated either with Th1 cytokines (TNF-α plus ...
The HER family of receptor tyrosine kinases has been linked to deregulation of growth and proliferat...
The HER family of receptor tyrosine kinases has been linked to deregulation of growth and proliferat...
SK-BR-3 and MDA-MB-468 cells were treated with either Th1 cytokines (TNF-α plus IFN-γ; 20 and 12.5ng...
A) IFN-γ ELISPOT assayof unfractionated human PBMCs from four unique donors stimulated with MHC clas...
Lapatinib is a specific HER1 and 2 targeted tyrosine kinase inhibitor now widely used in combination...
A) SKBR3 breast cancer cells were cultured in lapatinib till they gained resistance and started acti...
<p>A, Schematic showing the procedure to obtain cells resistant to anti-HER2 therapies <i>in vitro</...
Additional file 1: Fig. S1. (A) CRISPR-Cas9 library sequencing data analysis workflow. (B) The distr...
<p>A. Cellular proliferation of Calu3 and SkBr3 cells treated with different concentrations of lapat...
<p><b>A,</b> Lapatinib sensitivity curves in the parental OE19 and two lapatinib-resistant (LR) subc...